Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan‐cancer analysis
Abstract Objectives Lymphocyte activation gene 3 (LAG3), an inhibitory receptor in T‐cell activation, is a negative prognostic factor. However, its impact on tumours has yet to be comprehensively elucidated on a pan‐cancer scale. Thus, we aim to reveal its role at the pan‐cancer level. Methods We pe...
Saved in:
| Main Authors: | Yifan Liu, Yuntao Yao, Xinyue Yang, Maodong Wei, Bingnan Lu, Keqing Dong, Donghao Lyu, Yuanan Li, Wenbin Guan, Runzhi Huang, Guofeng Xu, Xiuwu Pan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Clinical & Translational Immunology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cti2.70009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The comprehensive potential of AQP1 as a tumor biomarker: evidence from kidney neoplasm cohorts, cell experiments and pan-cancer analysis
by: Yifan Liu, et al.
Published: (2025-02-01) -
NOX4 serves as a pan-cancer prognostic biomarker and therapeutic target in tumorigenesis
by: Jiting Sun, et al.
Published: (2025-07-01) -
ITGAV as a promising diagnostic, immunological, and prognostic biomarker in pan-cancer
by: Hanyang Su, et al.
Published: (2025-08-01) -
CD99 is a potential diagnostic and immunological biomarker in pan-cancer
by: Juntao Jiang, et al.
Published: (2025-08-01) -
Prognostic value and immunological role
of PTPN21 in pan-cancer analysis
by: Yane Yang, et al.
Published: (2023-07-01)